Table 1.
Therapeutic reagents modulating autophagy in anti-HCC treatment.
Reagents | Autophagy Target | Cells Treated | Result | Ref. |
---|---|---|---|---|
Sirolimus (Rapamycin) | mTOR | HepG2 | Upregulation of autophagy-cell death | [117,118] |
Temsirolimus (CCI-779) | mTOR | HepG2, Huh7 | Upregulation of autophagy-cell death | [119] |
Everolimus (RAD001) | mTOR | Hep3B, HepG2, Huh7 | Upregulation of autophagy-cell death | [120] |
Pemetrexed | mTORC1 | HepG2 | Upregulation of autophagy-cell death | [121] |
SC-59 | mTORC1 | PLC5, Sk-Hep1, HepG2 and Hep3B | Upregulation of autophagy-cell death | [122,123] |
BEZ235 | PI3K/mTOR | Hep3B, PLC/PRF/5 | Upregulation of autophagy-cell death | [124] |
MK-2206 | AKT | SNU449, SNU378, SNU475 | Upregulation of autophagy-cell death | [125] |
SB203580 | MAPK | HepG2, Hep3B, PLC/PRF/5, Huh-7 | Upregulation of autophagy-cell death | [126] |
Regorafenib | Tyrosine-kinase inhibitor | HepG2 and Hep3B | Upregulation of autophagy-cell death | [127] |
Sorafenib | Tyrosine-kinase inhibitor | Hep3B, HepG2, Huh7 | Upregulation of autophagy-cell death | [105,112] |
Nilotinib | Tyrosine kinase inhibitor | PLC5, Huh-7, Hep3B | Upregulation of autophagy-cell death | [128] |
ABT-737 | JNK pathway | Huh7, HepG2 | Upregulation of autophagy-cell death | [129] |
OSU-03012 | PDK1/AKT | Huh7, Hep3B, and HepG2 | Upregulation of autophagy-cell death | [130] |
5-FU | Induce ER stress | HepG2, SMMC-7721, Hep3B, BEL-7402 | Upregulation of autophagy-cell survival | [114] |
Bortezomib | Proteasome inhibitor | Huh7, HepG2, HuH7, human hepatocytes, rat hepatocytes | Upregulation of autophagy-cell death | [131] |
Chloroquine | Lysosome | HepG2, Huh7, HA22T/VGH, Mahlavu | Downregulation of autophagy-cell death | [132,133] |
3-MA | PI3K III | H22, HepG2, PLC/PRF/5, SMMC7721 | Downregulation of autophagy-cell death and cell survival | [134,135] |
Bafilomycin A1 | Lysosome | BEL7402, HepG2, Huh7, SMMC-7721 | Downregulation of autophagy-cell death | [136] |